|
Other Somatic Therapy
Citations 61-70 of 302 total displayed.
|
Past content
(since Feb 1996):
|
- Articles
Does Donepezil Treatment Slow the Progression of Hippocampal Atrophy in Patients With Alzheimer’s Disease?
- Mamoru Hashimoto, Hiroaki Kazui, Keiji Matsumoto, Yoko Nakano, Minoru Yasuda, and Etsuro Mori
Am J Psychiatry 2005; 162: 676-682.
[Abstract]
[Full text]
[PDF]
- Articles
Effect of Raloxifene on Prevention of Dementia and Cognitive Impairment in Older Women: The Multiple Outcomes of Raloxifene Evaluation (MORE) Randomized Trial
- Kristine Yaffe, Kathryn Krueger, Steven R. Cummings, Terri Blackwell, Victor W. Henderson, Somnath Sarkar, Kristine Ensrud, and Deborah Grady
Am J Psychiatry 2005; 162: 683-690.
[Abstract]
[Full text]
[PDF]
- Letters to the Editor
Mania in a Boy Treated With Modafinil for Narcolepsy
- FLORENCE VORSPAN, DOMINIQUE WAROT, ANGÈLE CONSOLI, DAVID COHEN, and PHILIPPE MAZET
Am J Psychiatry 2005; 162: 813-a-814-a.
[Full text]
[PDF]
- Letters to the Editor
Pramipexole, Ropinirole, and Mania in Parkinson’s Disease
- ABHAY SINGH, ROBERT ALTHOFF, R. JARED MARTINEAU, and JAMES JACOBSON
Am J Psychiatry 2005; 162: 814-a-815-a.
[Full text]
[PDF]
- Letters to the Editor
Memantine and Catatonic Schizophrenia
- CHRISTOPHER THOMAS
Am J Psychiatry 2005; 162: 626.
[Full text]
[PDF]
- Letters to the Editor
Neurotensin Receptor Agonists and Antagonists for Schizophrenia
- ELLIOTT RICHELSON, PAUL A. FREDRICKSON, and MONA M. BOULES
Am J Psychiatry 2005; 162: 633-b-634-b.
[Full text]
[PDF]
- Letters to the Editor
Neurotensin Receptor Agonists and Antagonists for Schizophrenia
- VIDA B. ROBERTSON and MICHAEL S. WILSON, II
Am J Psychiatry 2005; 162: 634.
[Full text]
[PDF]
- Letters to the Editor
Drs. Meltzer and Arvanitis Reply
- HERBERT Y. MELTZER and LISA ARVANITIS
Am J Psychiatry 2005; 162: 635.
[Full text]
[PDF]
- Articles
Methadone Versus Buprenorphine With Contingency Management or Performance Feedback for Cocaine and Opioid Dependence
- Richard S. Schottenfeld, Marek C. Chawarski, Juliana R. Pakes, Michael V. Pantalon, Kathleen M. Carroll, and Thomas R. Kosten
Am J Psychiatry 2005; 162: 340-349.
[Abstract]
[Full text]
[PDF]
- Brief Reports
Double-Blind, Placebo-Controlled, Multicenter Trial of Selegiline Augmentation of Antipsychotic Medication to Treat Negative Symptoms in Outpatients With Schizophrenia
- J. Alexander Bodkin, Samuel G. Siris, Paul C. Bermanzohn, John Hennen, and Jonathan O. Cole
Am J Psychiatry 2005; 162: 388-390.
[Abstract]
[Full text]
[PDF]
|
|
